blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2232270

EP2232270 - METHOD FOR ASSESSING RISK OF HEART FAILURE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.12.2013
Database last updated on 15.07.2024
Most recent event   Tooltip04.09.2015Lapse of the patent in a contracting state
New state(s): MT		published on 07.10.2015  [2015/41]
Applicant(s)For all designated states
McMaster University
McMaster Industry Liaison Office MIP Suite 100 175 Longwood Road South
Hamilton, Ontario L8S 1A1 / CA
[2013/07]
Former [2010/39]For all designated states
McMaster University
McMaster Industry Liaison Office MIP Suite 100 175 Longwood Road South
Hamilton, Ontario L8S 1A1 / CA
Inventor(s)01 / KAVSAK, Peter
2915 Westoak Trails Road
Oakville, Ontario L6M 4V2 / CA
 [2010/39]
Representative(s)Teuten, Andrew John, et al
Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[N/P]
Former [2013/19]Teuten, Andrew John, et al
Sagittarius IP
Three Globeside
Fieldhouse Lane
Marlow, Buckinghamshire SL7 1HZ / GB
Former [2013/07]Sagittarius IP
Three Globeside
Fieldhouse Lane
Marlow
Buckinghamshire SL7 1HZ / GB
Former [2010/39]Gibson, Mark
Sagittarius IP Taylor House 39 High Street Marlow
Buckinghamshire SL7 1AF / GB
Application number, filing date08863936.418.12.2008
[2010/39]
WO2008CA02236
Priority number, dateUS20070008594P21.12.2007         Original published format: US 8594 P
[2010/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009079773
Date:02.07.2009
Language:EN
[2009/27]
Type: A1 Application with search report 
No.:EP2232270
Date:29.09.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 02.07.2009 takes the place of the publication of the European patent application.
[2010/39]
Type: B1 Patent specification 
No.:EP2232270
Date:13.02.2013
Language:EN
[2013/07]
Search report(s)International search report - published on:CA02.07.2009
(Supplementary) European search report - dispatched on:EP28.02.2011
ClassificationIPC:G01N33/68, G01N33/53, G01N33/58, C12Q1/00
[2010/39]
CPC:
G01N33/6893 (EP,US); G01N33/6869 (EP,US); G01N2333/475 (EP,US);
G01N2333/485 (EP,US); G01N2333/523 (EP,US); G01N2333/5412 (EP,US);
G01N2333/5428 (EP,US); G01N2800/325 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/39]
TitleGerman:VERFAHREN ZUR BEURTEILUNG DER GEFAHR EINES HERZVERSAGENS[2010/39]
English:METHOD FOR ASSESSING RISK OF HEART FAILURE[2010/39]
French:PROCÉDÉ POUR ÉVALUER UN RISQUE D'ARRÊT CARDIAQUE[2010/39]
Entry into regional phase15.07.2010National basic fee paid 
15.07.2010Search fee paid 
15.07.2010Designation fee(s) paid 
15.07.2010Examination fee paid 
Examination procedure15.07.2010Examination requested  [2010/39]
23.09.2011Amendment by applicant (claims and/or description)
11.10.2011Despatch of a communication from the examining division (Time limit: M04)
13.02.2012Reply to a communication from the examining division
07.06.2012Cancellation of oral proceeding that was planned for 19.06.2012
19.06.2012Date of oral proceedings (cancelled)
26.07.2012Communication of intention to grant the patent
04.12.2012Fee for grant paid
04.12.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.10.2011
Opposition(s)14.11.2013No opposition filed within time limit [2014/04]
Fees paidRenewal fee
23.12.2010Renewal fee patent year 03
20.12.2011Renewal fee patent year 04
20.12.2012Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.12.2008
AT13.02.2013
BE13.02.2013
CY13.02.2013
CZ13.02.2013
DK13.02.2013
EE13.02.2013
FI13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
MT13.02.2013
NL13.02.2013
PL13.02.2013
RO13.02.2013
SE13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
[2015/41]
Former [2015/34]HU18.12.2008
AT13.02.2013
BE13.02.2013
CY13.02.2013
CZ13.02.2013
DK13.02.2013
EE13.02.2013
FI13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
NL13.02.2013
PL13.02.2013
RO13.02.2013
SE13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2015/32]AT13.02.2013
BE13.02.2013
CY13.02.2013
CZ13.02.2013
DK13.02.2013
EE13.02.2013
FI13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
NL13.02.2013
PL13.02.2013
RO13.02.2013
SE13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2015/30]AT13.02.2013
BE13.02.2013
CY13.02.2013
CZ13.02.2013
DK13.02.2013
EE13.02.2013
FI13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
NL13.02.2013
PL13.02.2013
RO13.02.2013
SE13.02.2013
SI13.02.2013
SK13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2014/38]AT13.02.2013
BE13.02.2013
CZ13.02.2013
DK13.02.2013
EE13.02.2013
FI13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
NL13.02.2013
PL13.02.2013
RO13.02.2013
SE13.02.2013
SI13.02.2013
SK13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/49]AT13.02.2013
BE13.02.2013
CZ13.02.2013
DK13.02.2013
EE13.02.2013
FI13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
NL13.02.2013
PL13.02.2013
RO13.02.2013
SE13.02.2013
SI13.02.2013
SK13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/48]AT13.02.2013
BE13.02.2013
DK13.02.2013
EE13.02.2013
FI13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
NL13.02.2013
PL13.02.2013
SE13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/41]AT13.02.2013
BE13.02.2013
FI13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
PL13.02.2013
SE13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/40]AT13.02.2013
BE13.02.2013
FI13.02.2013
LT13.02.2013
LV13.02.2013
PL13.02.2013
SE13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/38]AT13.02.2013
BE13.02.2013
FI13.02.2013
LT13.02.2013
LV13.02.2013
PL13.02.2013
SE13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
Former [2013/37]AT13.02.2013
FI13.02.2013
LT13.02.2013
PL13.02.2013
SE13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
Former [2013/36]AT13.02.2013
LT13.02.2013
PL13.02.2013
SE13.02.2013
BG13.05.2013
NO13.05.2013
IS13.06.2013
Former [2013/34]LT13.02.2013
SE13.02.2013
BG13.05.2013
NO13.05.2013
IS13.06.2013
Former [2013/33]LT13.02.2013
NO13.05.2013
Documents cited:Search[XA]  - TIAN Y ET AL, "The variation of serum cytokines in stress and coronary heart diseases", CLINICAL CHEMISTRY; 58TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-OF-CLINICAL-CHEMISTRY;CHICAGO, IL, USA; JULY 23 20060601 AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, (20060601), vol. 52, no. 6 supplement S, ISSN 0009-9147, page A139, XP008130550 [X] 8-13 * the whole document * [A] 1-7
 [XA]  - GUO G H ET AL, "To detect serum cytokines by using biochip technology", CLINICAL CHEMISTRY; ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CL INICAL-CHEMISTRY; ORLANDO, FL, USA; JULY 24 -28, 2005, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, (20050101), vol. 51, no. supplement 6, ISSN 0009-9147, page A119, XP008130551 [X] 8-13 * the whole document * [A] 1-7
 [X]  - FITZGERALD S PETE ET AL, "Simultaneous analysis of circulating human cytokines using a high-sensitivity cytokine biochip array.", JOURNAL OF PROTEOME RESEARCH JAN 2008 LNKD- PUBMED:18020322, (20071117), vol. 7, no. 1, ISSN 1535-3893, pages 450 - 455, XP002614263 [X] 8-13 * the whole document * * In particular: Abstract; p.50, col. 2, paragraph 2; Materials and methods section. *

DOI:   http://dx.doi.org/10.1021/PR070409O
International search[A]  - KAVSAK ET AL., "Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide", CLINICAL CHEMISTRY, (2007), vol. 53, no. 12, pages 2112 - 2118
 [A]  - KAVSAK ET AL., "Upstream markers'' provide for an early identification of patients at high risk for myocardial necrosis and adverse outcomes''", CLIN. CHEM. ACTA, (200801), vol. 387, no. 1-2, doi:doi:10.1016/j.cca.2007.09.023, pages 133 - 138, XP022332368

DOI:   http://dx.doi.org/10.1016/j.cca.2007.09.023
 [A]  - BIMER ET AL., HEAD-TO-HEAD COMPARISON OF BNP AND IL-6 AS MARKERS OF CLINICAL AND EXPERIMENTAL HEART FAILURE: SUPERIORITY OF BNP, (200711), vol. 40, no. 2, pages 89 - 97
ExaminationUS2006094056
by applicant   - KAVSAK ET AL., CLIN CHEM., (2007), vol. 53, pages 2112 - 2118
    - KAVSAK ET AL., CLIN CHEM ACTA, (2008), vol. 387, pages 133 - 138
    - TIAN ET AL., CLIN CHEM. 58TH ANNUAL MEETING, (2006), vol. 52, page A139
    - KAVSAK ET AL., CLIN CHEM., (2007), vol. 53, page 2115
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.